Clinical Trials Logo

Clinical Trial Summary

Spinal Cord Injury (SCI), being a devastating diagnosis, has little to no recovery which leads to a long-standing of debilitating impairment for affected patients. The National Neuroscience Institute (NNI) Neurosurgery team, together with our collaborators, will be embarking on a new clinical pilot trial named RESTORES: RESToration of Rehabilitative function with Epidural Spinal Stimulation. This study aims to investigate the feasibility of electrical stimulation via a spinal cord stimulator (SCS), which will be implanted into the study subjects, and advanced robotic neuro-rehabilitation to aid in improving neurological function in patients diagnosed with chronic SCI. A total of 3 patients, male and female participants, above the age of 21 who have been diagnosed with the condition for more than a year will be recruited for this study over a 2-year period. Rehab sessions will take place pre and post-surgical implant, assessing subject improvements.


Clinical Trial Description

Motor complete SCI is defined as American Spinal Injury Association (ASIA) impairment Grade A or B, with no motor function preserved below the level of injury. This in-turn results in significant catastrophic dysfunction and disability to the individual's physical and mental health, reducing quality of life and increasing caregiver burden which translates to high socioeconomic costs. The current treatments for chronic SCI involves aggressive rehabilitation to maximize residual neurological function and devices to compensate for neurological loss. However, neurological improvement is dismal, with 94.4% of patients demonstrating no neurological improvement 5-years post-injury. Experimental and electrophysiological observations revealed that spinal networks have the capacity to generate basic locomotor rhythmicity without supraspinal input to the cord. SCS, consisting of a small array of electrodes surgically implanted into the spinal epidural space stimulates afferent sensory pathways in specific patterns to drive voluntary and autonomically controlled motor responses. Activity-based training in conjunction with SCS has been shown to bolster neuroplasticity and recovery caudal to the injury site. The investigators aim to deliver epidural spinal stimulation via an implanted SCS and together with personalized advanced neuro-rehabilitation to study the improvement of neurological function after chronic SCI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05644171
Study type Interventional
Source National Neuroscience Institute
Contact Kai Rui Wan, MBBS
Phone 63577538
Email wan.kai.rui@singhealth.com
Status Recruiting
Phase N/A
Start date December 19, 2022
Completion date August 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04074616 - Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation N/A
Completed NCT00816803 - Cell Transplant in Spinal Cord Injury Patients Phase 1/Phase 2
Completed NCT05284201 - LIFT Home Study of Non-Invasive ARC Therapy for Spinal Cord Injury N/A
Completed NCT03458871 - Home Neuromodulation of the Neurogenic Bladder in Chronic Spinal Cord Injury With Transcutaneous Tibial Nerve Stimulation N/A
Active, not recruiting NCT02136823 - Impact of Persistent Conductances on Motor Unit Firing in SCI N/A
Completed NCT03989440 - AXER-204 in Participants With Chronic Spinal Cord Injury Phase 1/Phase 2
Completed NCT04697472 - The Up-LIFT Study of Non-Invasive ARC Therapy for Spinal Cord Injury N/A
Recruiting NCT05965700 - NVG-291 in Spinal Cord Injury Subjects Phase 1/Phase 2